Effect of CCH1 or MID1 gene disruption on drug tolerance and pathogenesis of Candida albicans

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 28, Issue 6, 2012, Pages 726-736

  Wang, Hui ^a,b   Lu, Guangqing ^a   Yang, Baopeng ^a   Wang, Fan ^a   Yu, Qilin ^a   Xu, Ning ^a   Cheng, Xinxin ^a   Xing, Laijun ^a   Li, Mingchun ^a  

^a NANKAI UNIVERSITY   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

Candida albicans; CCH1; Drug tolerance; MID1; Pathogenesis

Indexed keywords

CALCINEURIN; CALCIUM; CALCIUM CHANNEL; FUNGAL PROTEIN;

ANIMAL; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DRUG EFFECT; FEMALE; GENE DELETION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; VIRULENCE;

ANIMALS; CALCINEURIN; CALCIUM; CALCIUM CHANNELS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGAL PROTEINS; GENE DELETION; MICE; MICE, INBRED ICR; VIRULENCE;

ANIMALIA; CANDIDA ALBICANS;

EID: 84865650458     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Koh AY, Köhler JR, Coggshall KT, et al. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog, 2008, 4 (2): e35.
2. Ruhnke M, Maschmeyer G. Management of mycoses in patients with hematologic disease and cancer-review of the literature. Eur J Med Res, 2002, 7 (5): 227-235.
3. Andes D, Forrest A, Lepak A, et al. Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: Fluconazole and Candida albicans. Antimicrob Agents Chemother, 2006, 50 (7): 2374-2383.
4. Edlind T, Smith L, Henry K, et al. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling. Mol Microbiol, 2002, 46 (1): 257-268.
5. Kaur R, Castaño I, Cormack BP. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: Roles of calcium signaling and mitochondria. Antimicrob Agents Chemother, 2004, 48 (5): 1600-1613.
6. 2+ entry: Evidence for a secretion-like coupling model. Cell, 1999, 98 (4): 487-499.
7. 2+ signaling is required for survival of endoplasmic reticulum stress in yeast. Mol Biol Cell, 2003, 14 (10): 4296-4305.
8. 2+ channel Cch1pMid1p is essential for tolerance to cold stress and iron toxicity. FEBS Lett, 2005, 579 (25): 5697-5703.
9. Aramburu J, Heitman J, Crabtree GR. Calcineurin: A central controller of signalling in eukaryotes. EMBO Rep, 2004, 5 (4): 343-348.
10. Sanglard D, Ischer F, Marchetti O, et al. Calcineurin A of Candida albicans: Involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol, 2003, 48 (4): 959-976.
11. Wu T, Wright K, Hurst SF, et al. Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole. Antimicrob Agents Chemother, 2000, 44 (5): 1200-1208.
12. Li Y, Sun SJ, Guo QJ, et al. In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemother, 2008, 61 (3): 577-585.
13. Bonilla M, Nastase KK, Cunningham KW. Essential role of calcineurin in response to endoplasmic reticulum stress. EMBO J, 2002, 21 (10): 2343-2353.
14. Wang H, Xu N, Xing LJ, et al. Effect of CCH1 and MID1 in calcium influx under alkaline pH and its regulation by Crz1p transcription factor in Candida albicans. Chin J Biotech, 2011, 27 (6): 917-925.
15. CLSI/NCCLS, Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, 2002.
16. Pfaller MA, Messer SA, Bolmström A, et al. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol, 1996, 34 (7): 1691-1693.
17. Krasowska A, Murzyn A, Dyjankiewicz A, et al. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res, 2009, 9 (8): 1312-1321.
18. Schaller M, Januschke E, Schackert C, et al. Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo. J Med Microbiol, 2001, 50 (8): 743-747.
19. Costa CR, Jesuíno RSA, de Aquino Lemos J, et al. Effects of antifungal agents in sap activity of Candida albicans isolates. Mycopathologia, 2010, 169 (2): 91-98.
20. Fekete-Forgács K, Gyüre L, Lenkey B. Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans. Mycoses, 2000, 43 (7/8): 273-279.
21. Jayatilake JAMS, Samaranayake YH, Cheung LK, et al. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J Oral Pathol Med, 2006, 35 (8): 484-491.